2022 annual financial data
ADC Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -65.89%.
Operating income was -123,344,000 USD and net income was -157,128,000 USD.
Operating cash flow was -138,311,000 USD.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 209,908,000 USD
- Operating income
- -123,344,000 USD
- Net income
- -157,128,000 USD
- Operating cash flow
- -138,311,000 USD